BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 6413684)

  • 1. II. Unbound versus total serum gold concentration: pharmacological actions on cellular function.
    Lorber A; Kunishima DH; Harralson AF; Simon TM
    J Rheumatol; 1983 Aug; 10(4):568-73. PubMed ID: 6413684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. I. Unbound serum gold: procedure for quantitation.
    Lorber A; Vibert GJ; Harralson AF; Simon TM
    J Rheumatol; 1983 Aug; 10(4):563-7. PubMed ID: 6413683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-bound gold (CBG) in patients treated with aurothioglucose and with auranofin. A comparison of different methods of determination.
    van Riel PL; Gribnau FW; van de Putte LB
    J Rheumatol; 1983 Aug; 10(4):574-8. PubMed ID: 6413685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Distribution of gold from aurothiomalate and gold trielthylphosphine in whole blood, lymphocytes and lymphocyte chromatin of patients with chronic polyarthritis].
    Teherani DK; Altmann H; Tausch G; Eberl R
    Wien Klin Wochenschr Suppl; 1984; 156():53-5. PubMed ID: 6442060
    [No Abstract]   [Full Text] [Related]  

  • 5. The efficacy of parenteral gold after auranofin failure in rheumatoid arthritis.
    Wessel J; Davis P
    J Rheumatol; 1983 Aug; 10(4):664. PubMed ID: 6413690
    [No Abstract]   [Full Text] [Related]  

  • 6. Auranofin.
    Davis P
    Clin Rheum Dis; 1984 Aug; 10(2):369-83. PubMed ID: 6239742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gold in rheumatoid arthritis; the past, present and future. Proceedings of a symposium held in Copenhagen, April 15-16, 1983.
    Scand J Rheumatol Suppl; 1983; 51():1-139. PubMed ID: 6426042
    [No Abstract]   [Full Text] [Related]  

  • 8. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
    Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P
    Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitation of gold lymphocyte binding during chrysotherapy.
    Lorber A; Wilcox S; Leeb J; Simon T
    J Rheumatol; 1979; 6(3):270-6. PubMed ID: 114635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experiences to date with oral gold therapy].
    Zeidler H
    Wien Klin Wochenschr Suppl; 1984; 156():22-7. PubMed ID: 6442052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral chrysotherapy in rheumatoid arthritis: auranofin. Cleveland Clinic experience and literature review.
    Mazanec DJ; Segal AM; Mackenzie AH; Lippert M
    Cleve Clin Q; 1985; 52(2):123-8. PubMed ID: 3928200
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of immune response during chrysotherapy. Comparison of gold sodium thiomalate vs. auranofin.
    Lorber A; Jackson WH; Simon TM
    Scand J Rheumatol; 1981; 10(2):129-37. PubMed ID: 6787702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intracellular gold content of circulating blood cells using various gold compounds].
    Herrlinger JD; Beress R; Hecker U
    Wien Klin Wochenschr Suppl; 1984; 156():13-6. PubMed ID: 6442048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of auranofin dose regimen change upon cell-associated gold in rheumatoid arthritic patients.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1981; 8(5):829-32. PubMed ID: 6796684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of gold in blood following administration of auranofin (SK&F D-39162).
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol Suppl; 1979; 5():56-60. PubMed ID: 114638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo-controlled comparison of oral gold with injectable gold in early rheumatoid arthritis.
    Davies J; Bacon PA; Hall ND; Ring EF
    Clin Rheumatol; 1984 Dec; 3(4):553-4. PubMed ID: 6441670
    [No Abstract]   [Full Text] [Related]  

  • 18. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
    Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of auranofin and gold sodium aurothiomalate on the chemiluminescent response of stimulated synovial tissue cells from patients with rheumatoid arthritis.
    Harth M; McCain GA; Orange JF
    J Rheumatol; 1985 Oct; 12(5):881-4. PubMed ID: 3936929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the kinetics of parenteral and oral gold.
    Gottlieb NL
    Scand J Rheumatol Suppl; 1983; 51():10-4. PubMed ID: 6426043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.